Ingredients

CordenPharma increases peptide production capacity

Following the signature of a multi-year large scale peptide manufacturing agreement earlier this year, CordenPharma has announced the inauguration of increased commercial peptide production capacity with newly-upgraded facilities

Breaking News

Actylis adds a WFI production system in Canada

The manufacturer of raw materials has launched a Water for Injection (WFI) and additional ISO Class 7 manufacturing in Montreal, Canada

Orbit partners Orano on peptide radionuclide therapies

Orbit Discovery and Orano Med have entered a collaboration to discover novel targeted radioligand therapies for cancer treatment

Salipro partners Sumitomo on pharmacological characterisations of drug candidates

The two companies have entered into a collaboration that leverages Salipro's platform technology to investigate the pharmacological characteristics...

CPHI Barcelona 2023: forging collaborations for a promising future in the pharmaceutical sector

CPHI Barcelona is set to take centre stage from 24–26 October at Fira Barcelona Gran Via, Spain. Building on its legacy of excellence, this year’s...

Navigating CMC challenges in NBE and therapeutic antibody development

Insights by Dr Thomas Flad, Senior Director of Solutions & Innovation at ProtaGene, as he poses solutions to the difficulty matching analytical res...

CordenPharma increases peptide production capacity

Following the signature of a multi-year large scale peptide manufacturing agreement earlier this year, CordenPharma has announced the inauguration...

Small molecules: big market opportunities

The rapid rise of biologic drugs in recent years has been accompanied by a market narrative that suggests that innovation and new treatments will b...

FUJIFILM launches viral vector feed designed to increase yields

FUJIFILM Irvine Scientific has launched its BalanCD HEK293 Viral Feed designed to boost adeno-associated viral vector (AAV) production for gene the...

LEHVOSS expands compounding facility in China

The company has relocated to a different site which means it can expand its high-performance compounding and pharmaceutical technology capabilities

Charles River announces plasmid manufacturing collaboration with Fondazione Telethon

The two companies have agreed on a manufacturing collaboration that will produce pDNA, used to produce GMP lentivirus for ex vivo gene therapy

Experience is everything: excipients and their role in enhancing patient-centricity

It’s a hard pill to swallow, but medication adherence is one of the toughest challenges facing the pharmaceutical industry today, writes Arnaud Ver...

Catalent signs development deal with Ethicann for new fast-dissolve cannabinoid treatment

Catalent and Canadian/US cannabinoid drug therapy company Ethicann Pharmaceuticals have executed a development and license agreement that will use...

Sirio Pharma targets consumer health at CPHI Barcelona

The pharmaceutical company is set to appear at CPHI Barcelona and showcase three ingredients to help maintain eye health, with new ready-to market...

What does 2023 hold for oral solid dosage forms?

Recipharm’s Uwe Hanenberg, Head of Product Development, Oral Solid Dose, and Maria Lundin-Johnson, Head of Formulation Development, explore the lat...

Graft Polymer signs manufacturing agreement for haemostatic agent

Graft Polymer has been contracted by the partner to produce its patented haemostatic powder following a recent, successful pilot scheme

The trend for customised raw materials and outsourced buffer manufacturing

Customisation in biopharmaceuticals usually comes into play when standard excipients with slightly different purity profiles are required. For exam...